These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19499513)

  • 21. Mid-trimester placentation assessment in high-risk pregnancies using maternal serum screening and uterine artery Doppler.
    Hershkovitz R; de Swiet M; Kingdom J
    Hypertens Pregnancy; 2005; 24(3):273-80. PubMed ID: 16263599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal serum activin a at 11-13 weeks of gestation in hypertensive disorders of pregnancy.
    Akolekar R; Etchegaray A; Zhou Y; Maiz N; Nicolaides KH
    Fetal Diagn Ther; 2009; 25(3):320-7. PubMed ID: 19776595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.
    Spencer K; Yu CK; Cowans NJ; Otigbah C; Nicolaides KH
    Prenat Diagn; 2005 Oct; 25(10):949-53. PubMed ID: 16086443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal changes in maternal soluble endoglin and angiopoietin-2 in women at risk for pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Elkhouli M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2014 Oct; 44(4):402-10. PubMed ID: 24913462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11-13 weeks.
    Poon LC; Karagiannis G; Leal A; Romero XC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 Nov; 34(5):497-502. PubMed ID: 19827052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11-13 weeks.
    Poon LC; Akolekar R; Lachmann R; Beta J; Nicolaides KH
    Ultrasound Obstet Gynecol; 2010 Jun; 35(6):662-70. PubMed ID: 20232288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiopoietin 1 and 2 serum concentrations in first trimester of pregnancy as biomarkers of adverse pregnancy outcomes.
    Schneuer FJ; Roberts CL; Ashton AW; Guilbert C; Tasevski V; Morris JM; Nassar N
    Am J Obstet Gynecol; 2014 Apr; 210(4):345.e1-345.e9. PubMed ID: 24215861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia.
    Akolekar R; de Cruz J; Foidart JM; Munaut C; Nicolaides KH
    Prenat Diagn; 2010 Mar; 30(3):191-7. PubMed ID: 20101671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uterine artery Doppler at 11-14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population.
    Gómez O; Martínez JM; Figueras F; Del Río M; Borobio V; Puerto B; Coll O; Cararach V; Vanrell JA
    Ultrasound Obstet Gynecol; 2005 Oct; 26(5):490-4. PubMed ID: 16184511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of uterine artery Doppler in interpreting low PAPP-A values in first-trimester screening for Down syndrome in pregnancies at high risk of impaired placentation.
    Herraiz I; López-Jiménez EA; García-Burguillo A; Nieto O; Villar OP; Escribano D; Galindo A
    Ultrasound Obstet Gynecol; 2009 May; 33(5):518-23. PubMed ID: 19402101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First-trimester maternal serum tumor necrosis factor receptor-1 and pre-eclampsia.
    Leal AM; Poon LC; Frisova V; Veduta A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 Feb; 33(2):135-41. PubMed ID: 19173240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal serum angiopoietin-1 and -2 and tie-2 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
    Leinonen E; Wathén KA; Alfthan H; Ylikorkala O; Andersson S; Stenman UH; Vuorela P
    J Clin Endocrinol Metab; 2010 Jan; 95(1):126-33. PubMed ID: 19875484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First-trimester placental growth factor as a marker for hypertensive disorders and SGA.
    Cowans NJ; Stamatopoulou A; Matwejew E; von Kaisenberg CS; Spencer K
    Prenat Diagn; 2010 Jun; 30(6):565-70. PubMed ID: 20509158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal serum resistin at 11 to 13 weeks' gestation in normal and pathological pregnancies.
    Nanda S; Poon LC; Muhaisen M; Acosta IC; Nicolaides KH
    Metabolism; 2012 May; 61(5):699-705. PubMed ID: 22146093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia.
    Poon LC; Maiz N; Valencia C; Plasencia W; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 Jan; 33(1):23-33. PubMed ID: 19090499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of antihypertensive therapy with alpha-methyldopa on uterine artery Doppler in pregnancies with hypertensive disorders.
    Khalil A; Harrington K; Muttukrishna S; Jauniaux E
    Ultrasound Obstet Gynecol; 2010 Jun; 35(6):688-94. PubMed ID: 20201113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiopoietin-1 and angiopoietin-2 as serum biomarkers for ectopic pregnancy and missed abortion: a case-control study.
    Daponte A; Deligeoroglou E; Pournaras S; Tsezou A; Garas A; Anastasiadou F; Hadjichristodoulou C; Messinis IE
    Clin Chim Acta; 2013 Jan; 415():145-51. PubMed ID: 23099117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal Plasma Nerve Growth Factor at the 11+0-13+6 Weeks' Scan as a Potential Angiogenic Marker of Preeclampsia: A Pilot Study.
    Sepúlveda-Martínez A; Garrido M; Caamano E; Vega M; Romero C; Parra-Cordero M
    Fetal Diagn Ther; 2017; 41(3):202-208. PubMed ID: 27513943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Competing risk model in screening for preeclampsia by mean arterial pressure and uterine artery pulsatility index at 30-33 weeks' gestation.
    Tayyar A; Garcia-Tizon Larroca S; Poon LC; Wright D; Nicolaides KH
    Fetal Diagn Ther; 2014; 36(1):18-27. PubMed ID: 24970282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia.
    Spencer K; Cowans NJ; Chefetz I; Tal J; Meiri H
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):128-34. PubMed ID: 17149788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.